Key players in the
moderately fragmented global assisted reproductive technology market
include Merck, CooperSurgical, Inc., Irvine Scientific, Vitrolife AB,
Hamilton Thorne, Inc., Nidacon International AB, Laboratoire CCD,
Planer PLC, Esco Micro Pte. Ltd. (Esco Group), and Nikon Corporation.
Merck holds a dominant share in the global assisted reproductive
technology market due to its widespread portfolio and steady presence
in various regional markets.
Request for
Sample Copy of Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=29234
According to
Transparency Market Research, the global assisted reproductive
technology market is expected to be worth US$37,789.6 mn by the end
of 2025 from US$22,100.0 mn in 2016. Between the forecast years of
2017 and 2025, the global market is expected to rise at a CAGR of
6.3%. The fresh non donor segment accounted for a leading share in
the global assisted reproductive technology market in 2016 and is
likely to remain similarly dominant in the coming years.
Geographically, Asia Pacific is the leading contributor to the global
assisted reproductive technology market and is likely to retain a
leading share in the global market in the coming years.
By technology, the
global assisted reproductive technology market is divided into
artificial insemination, in vitro fertilization, surrogacy, and
others. In vitro fertilization is by far the dominant contributor to
the global assisted reproductive technology market at present and is
likely to retain the position in the coming years due to the growing
awareness about the efficacy of in vitro fertilization and the
increasing awareness among citizens about the same. The in vitro
fertilization segment accounted for a majority share of more than 62%
in the global assisted reproductive technology market in 2016 and is
likely to extend its dominance further by the end of the 2017-2025
forecast period.
Enquiry for
discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=29234
Surrogacy is also
likely to receive increasing demand in the coming years, due in part
to the growing demand for assisted reproductive technology from
same-sex couples. While many parents now prefer the benefit of having
their own genetic imprint in their baby through in vitro
fertilization, surrogacy is likely to receive sustained demand in the
coming years. This is borne out by the figures of the global assisted
reproductive technology market by procedure, wherein fresh non donor
contributions were the preferred choice for most consumers.
Developing economies
in Asia Pacific are likely to be vital to the global assisted
reproductive technology market in the coming years. While the
predominant social values in these regions tended to dissuade
constructive growth of the assisted reproductive technology market,
the gradual relaxation in social norms in these regions has resulted
in a promising environment for the market. The growing prevalence of
reproductive problems in Asia Pacific countries such as India and
China is thus crucial to the global assisted reproductive technology
market.
The growing
investment in the healthcare sector in developing countries is also
likely to provide a major boost to the global assisted reproductive
technology market in the coming years. This will help increase the
frequency of fertility clinics in underdeveloped regions, where
sophisticated medical facilities may still be absent.
Report Overview @
https://www.transparencymarketresearch.com/assisted-reproductive-technology-market.html
The steady
development of preimplantation genetic diagnosis (PGD) is a key
driver for the global assisted reproductive technology market. PGD
helps physicians diagnose genetic disorders likely to manifest in the
baby before it is implanted, making the technology vital for parents
looking to avoid complicated births and lifestyles. The rapid
development of the scientific database regarding genetic diseases is
further likely to remain a key boost for the global assisted
reproductive technology market.
About Us
Transparency Market
Research (TMR) is a market intelligence company, providing global
business information reports and services. Our exclusive blend of
quantitative forecasting and trends analysis provides forward-looking
insight for thousands of decision makers. TMR’s experienced team of
analysts, researchers, and consultants, use proprietary data sources
and various tools and techniques to gather, and analyze information.
Our business offerings represent the latest and the most reliable
information indispensable for businesses to sustain a competitive
edge.
Each TMR syndicated
research report covers a different sector - such as pharmaceuticals,
chemicals, energy, food & beverages, semiconductors, med-devices,
consumer goods and technology. These reports provide in-depth
analysis and deep segmentation to possible micro levels. With wider
scope and stratified research methodology, TMR’s syndicated reports
strive to provide clients to serve their overall research
requirement.
US Office
Contact
90 State Street,
Suite 700
Albany, NY 12207
Tel:
+1-518-618-1030
USA - Canada Toll
Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment